The current valuation score of ACADIA Pharmaceuticals Inc is 7.26, ranking 191 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 11.60, which is 790.89% below the recent high of 103.35 and 18735.92% above the recent low of -2161.97.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.